Alnylam Pharmaceuticals, Inc. (DUL.F)
Makes medicines that use RNA to treat rare genetic and metabolic diseases.
252.20-0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-26.0%
The outlook
Alnylam Pharmaceuticals is trading near its 52-week low, well below both its 50- and 200-day moving averages, signaling a downtrend. The stock carries a high trailing P/E of 71.9 and shows a bearish technical setup. Analyst coverage appears thin on this listing.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Market cap
$33.67B
52-wk high
423.00
52-wk low
231.60
50-day avg
253.65
200-day avg
297.53
Trailing P/E
71.9